drugset / Trial / NCT03593811

Noninvasive Markers of Functional Nausea in Children

NCT03593811

Phase 0 Completed 42 enrolled Vanderbilt University Medical Center
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The researchers propose to study how functional nausea in adolescents may be characterized noninvasively by the use of multichannel electrogastrogram (EGG) and magnetogastrogram (MGG) recordings.

Timeline

Start
2018-08-03
Primary completion
2021-04-02
Completion
2021-04-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyproheptadine Small molecule 4 mg
Comparator Ondansetron Other / unclassified 4 mg
Comparator Ondansetron Other / unclassified 8 mg

Indications

No indication recorded.